Pharmacovigilance / Biological Therapies working GROUP


  • Establish a common task force for the screening, preventive vaccinations, correct use and monitoring of biologic treatments in immune mediated diseases
  • Complete survey of current registers within the constituent themes
  • Establish a common tool for pharmacovigilance in these rare conditions
  • Complete gap analysis & agree on a common action plan for prospective surveillance on biologicals, biosimilars and targeted therapies such as small molecule-drugs